CIP
CTKB icon

Cornerstone Investment Partners’s Cytek Biosciences CTKB Stock Holding History

Cornerstone Investment Partners’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-31,411
Closed -$204K – 210
2024
Q4 		$204K Buy
+31,411
New +$187K 0.01% 198
2024
Q3 		– Sell
-23,554
Closed -$131K – 244
2024
Q2 		$131K Sell
23,554
-1,900
-7% -$11.4K 0.01% 215
2024
Q1 		$171K Buy
+25,454
New +$201K 0.01% 204
2022
Q3 		– Sell
-18,440
Closed -$198K – 206
2022
Q2 		$198K Buy
+18,440
New +$184K 0.01% 155
2022
Q1 		– Sell
-11,500
Closed -$188K – 239
2021
Q4 		$188K Buy
+11,500
New +$241K 0.01% 261

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cornerstone Investment Partners's CTKB Position: Q1 2025 in Review

Cornerstone Investment Partners sold out of Cytek Biosciences (CTKB) in Q1 2025, closing a stake of 31,411 shares — an estimated $204K sold.

Cornerstone Investment Partners first reported a position in CTKB in Q4 2021 and held it in 5 quarters. The position peaked at $204K in Q4 2024. 160 funds tracked by Wall St. Rank hold CTKB as of Q1 2025.

  • Cornerstone Investment Partners reported no remaining Cytek Biosciences position as of Q1 2025 after selling out during the quarter.
  • Cornerstone Investment Partners sold 31,411 Cytek Biosciences shares in Q1 2025, an estimated $204K.
  • Cornerstone Investment Partners first reported a position in Cytek Biosciences in Q4 2021 and held it in 5 quarters.
  • Cornerstone Investment Partners's Cytek Biosciences position peaked at $204K in Q4 2024.
  • 160 funds tracked by Wall St. Rank held Cytek Biosciences as of Q1 2025.

Based on Cornerstone Investment Partners's 13F filing for Q1 2025, filed 30 Apr 2025.